Antonio Hardan is professor in the Department of Psychiatry and Behavioral Sciences at Stanford University, where he is the Carl Feinstein Director of the Child and Adolescent Psychiatry Division. He is also the director of the Autism and Developmental Disorders Clinic at Lucile Packard Children’s Hospital at Stanford. Hardan is a board-certified child and adolescent psychiatrist and a general psychiatrist with more than 20 years’ experience assessing and treating children and adults with developmental disorders, including autism spectrum disorder (ASD), velocardiofacial syndrome and Down syndrome. He has won several teaching awards, including the John Romano Award (University of Rochester) and the Outstanding Teacher award (Stanford University).
Hardan’s research focuses on the neurobiology of ASD and the development of innovative treatments for individuals with neurodevelopmental disorders. He has served as a principal investigator on numerous projects examining the neurobiology of ASD and assessing the effectiveness of a wide range of interventions. He is the recipient of several grants examining the efficacy of Pivotal Response Treatment and vasopressin in the treatment of children with ASD. He has completed several investigations aimed at increasing our understanding of the pathophysiology of individuals with developmental disorders by applying multimodal imaging techniques. He has also led several clinical trials examining the effectiveness of novel interventions, such as N-acetylcysteine in children with ASD and everolimus for individuals with PTEN mutations. Hardan has published more than 100 journal articles and has coauthored several book chapters in the field of developmental disorders and ASD.